title: Indications for stenting during thrombolysis.
abstract: The most important vein segment to thrombolyse after deep venous thrombosis (DVT) is the outflow tract meaning the iliofemoral vein. Iliofemoral DVT is defined as DVT in the iliac vein and the common femoral vein. Spontaneous recanalization is less than 50%, particularly on the left side. The compression from adjacent structures, predominantly on the left side is known as the iliac vein compression syndrome. Therefore, it is essential that supplementary endovenous procedures have to be performed in case of persistent obstructive lesions following catheter-directed thrombolysis. Insertion of a stent in this position is the treatment of choice facilitating the venous flow into an unobstructed outflow tract either from the femoral vein or the deep femoral vein or both. The stent, made of stainless steel or nitinol, has to be self-expandable and flexible with radial force to overcome the challenges in this low-pressure system. The characteristics of the anatomy with external compression and often a curved vein segment with diameter difference make stent placement necessary. Ballooning alone has no place in this area. The proportion of inserted stents varies in the published materials with catheter-directed thrombolysis of iliofemoral deep venous thrombosis.
authors.affiliation: Vascular Clinic, Gentofte Hospital and Rigshospitalet, Niels Andersensvej 65, DK-2900 Hellerup, Copenhagen, Denmark. baekgaard@dadlnet.dk
authors.forename: N
authors.initials: N
authors.lastname: Bækgaard
authors.forename: R
authors.initials: R
authors.lastname: Broholm
authors.forename: S
authors.initials: S
authors.lastname: Just
mesh_terms: D057510:Endovascular Procedures / Q000295:instrumentation*; D005268:Femoral Vein / Q000503:physiopathology; D006801:Humans; D007084:Iliac Vein / Q000503:physiopathology; D062108:May-Thurner Syndrome / Q000150:complications / Q000503:physiopathology / Q000628:therapy*; D018579:Patient Selection; D054070:Postthrombotic Syndrome / Q000209:etiology / Q000517:prevention & control; D011474:Prosthesis Design; D012039:Regional Blood Flow; D015607:Stents; D015912:Thrombolytic Therapy; D016896:Treatment Outcome; D020246:Venous Thrombosis / Q000209:etiology / Q000503:physiopathology / Q000628:therapy*